On day 1, GLP-1 was infused to stimulate endogenous insulin release and suppress endogenous glucagon. On days 2–5, pancreatic endocrine clamps were performed using somatostatin infusions of ...

The company estimates that its install base surpassed 15,000 by the end of last year, leading to sales of more than $20 ...

The endocrine cells release insulin and glucagon, two hormones that help regulate blood sugar in the body. Despite the pancreas being responsible for multiple functions, there are circumstances in ...

GLP-1 drugs mimic a hormone that sends the brain signals of fullness. Researchers theorize that the drugs could work the same ...

Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as ...

CHICAGO and ARLINGTON, Va. - The American Diabetes Association and a national supporter, Xeris Pharmaceuticals, have formed a multi-year strategic partnership to reinforce the importance of prescribin ...

Studies have suggested that GLP-1RAs may show promise for a host of conditions, from alcohol use disorder to Parkinson’s. But ...

Xeris Pharmaceuticals has teamed up with the American Diabetes Association (ADA) to raise awareness of the importance of ...

Traditionally, blood sugar regulation has been attributed to the hormones insulin and glucagon, both produced by the pancreas. Insulin lowers blood glucose by promoting its uptake into cells ...

Glucagon is a hormone produced by α cells in the pancreas. It works alongside insulin to regulate blood sugar levels, raising them when they drop too low. However, in people with type 2 diabetes ...

It performs both exocrine and endocrine functions. The exocrine cells release digestive enzymes to assist with breaking down food. The endocrine cells release insulin and glucagon, two hormones that ...

glucagon-like peptides stimulate your pancreas to produce more insulin; slow stomach emptying semaglutide (Ozempic), dulaglutide (Trulicity), exenatide (Byetta), and liraglutide (Victoza ...